MX2020002643A - Variantes relacionadas con el receptor de inmunoglobulina interleucina 1 simple (sigirr) y usos de estas. - Google Patents
Variantes relacionadas con el receptor de inmunoglobulina interleucina 1 simple (sigirr) y usos de estas.Info
- Publication number
- MX2020002643A MX2020002643A MX2020002643A MX2020002643A MX2020002643A MX 2020002643 A MX2020002643 A MX 2020002643A MX 2020002643 A MX2020002643 A MX 2020002643A MX 2020002643 A MX2020002643 A MX 2020002643A MX 2020002643 A MX2020002643 A MX 2020002643A
- Authority
- MX
- Mexico
- Prior art keywords
- sigirr
- nucleic acid
- acid molecules
- disclosure
- receptor related
- Prior art date
Links
- 108060003951 Immunoglobulin Proteins 0.000 title abstract 2
- 102000045959 Interleukin-1 Receptor-Like 1 Human genes 0.000 title abstract 2
- 108700003107 Interleukin-1 Receptor-Like 1 Proteins 0.000 title abstract 2
- 102000018358 immunoglobulin Human genes 0.000 title abstract 2
- 101150034627 SIGIRR gene Proteins 0.000 title 1
- 102000039446 nucleic acids Human genes 0.000 abstract 3
- 108020004707 nucleic acids Proteins 0.000 abstract 3
- 150000007523 nucleic acids Chemical class 0.000 abstract 3
- 230000004075 alteration Effects 0.000 abstract 2
- 101000652846 Homo sapiens Single Ig IL-1-related receptor Proteins 0.000 abstract 1
- 208000022559 Inflammatory bowel disease Diseases 0.000 abstract 1
- 239000002299 complementary DNA Substances 0.000 abstract 1
- 102000045863 human SIGIRR Human genes 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/06—Gastro-intestinal diseases
- G01N2800/065—Bowel diseases, e.g. Crohn, ulcerative colitis, IBS
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Analytical Chemistry (AREA)
- Wood Science & Technology (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Pathology (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Peptides Or Proteins (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762554857P | 2017-09-06 | 2017-09-06 | |
| PCT/US2018/049478 WO2019050899A1 (en) | 2017-09-06 | 2018-09-05 | SINGLE IMMUNOGLOBULIN INTERLEUKIN 1 (SIGIRR) RELATED INTERCEPTOR-RELATED VARIANTS AND USES THEREOF |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2020002643A true MX2020002643A (es) | 2020-09-25 |
Family
ID=63708447
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2020002643A MX2020002643A (es) | 2017-09-06 | 2018-09-05 | Variantes relacionadas con el receptor de inmunoglobulina interleucina 1 simple (sigirr) y usos de estas. |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US20210071251A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP3679158B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP7237064B2 (cg-RX-API-DMAC7.html) |
| KR (1) | KR102752108B1 (cg-RX-API-DMAC7.html) |
| CN (1) | CN111373053B (cg-RX-API-DMAC7.html) |
| AU (1) | AU2018328120B2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3074652A1 (cg-RX-API-DMAC7.html) |
| DK (1) | DK3679158T3 (cg-RX-API-DMAC7.html) |
| ES (1) | ES3034207T3 (cg-RX-API-DMAC7.html) |
| FI (1) | FI3679158T3 (cg-RX-API-DMAC7.html) |
| IL (1) | IL272940B2 (cg-RX-API-DMAC7.html) |
| MX (1) | MX2020002643A (cg-RX-API-DMAC7.html) |
| NZ (1) | NZ762152A (cg-RX-API-DMAC7.html) |
| SG (1) | SG11202001754RA (cg-RX-API-DMAC7.html) |
| WO (1) | WO2019050899A1 (cg-RX-API-DMAC7.html) |
Family Cites Families (32)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4399216A (en) | 1980-02-25 | 1983-08-16 | The Trustees Of Columbia University | Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials |
| US5179017A (en) | 1980-02-25 | 1993-01-12 | The Trustees Of Columbia University In The City Of New York | Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials |
| US4634665A (en) | 1980-02-25 | 1987-01-06 | The Trustees Of Columbia University In The City Of New York | Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials |
| US4751180A (en) | 1985-03-28 | 1988-06-14 | Chiron Corporation | Expression using fused genes providing for protein product |
| US4935233A (en) | 1985-12-02 | 1990-06-19 | G. D. Searle And Company | Covalently linked polypeptide cell modulators |
| US5294533A (en) | 1988-07-05 | 1994-03-15 | Baylor College Of Medicine | Antisense oligonucleotide antibiotics complementary to the macromolecular synthesis operon, methods of treating bacterial infections and methods for identification of bacteria |
| US5135917A (en) | 1990-07-12 | 1992-08-04 | Nova Pharmaceutical Corporation | Interleukin receptor expression inhibiting antisense oligonucleotides |
| US5271941A (en) | 1990-11-02 | 1993-12-21 | Cho Chung Yoon S | Antisense oligonucleotides of human regulatory subunit RI.sub.α of cAMP-dependent protein kinases |
| US5786138A (en) | 1993-01-29 | 1998-07-28 | Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College | Hyperstabilizing antisense nucleic acid binding agents |
| AU693097B2 (en) | 1993-06-04 | 1998-06-25 | Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The | Method for treating kaposi's sarcoma with antisense oligonucleotides |
| US5578716A (en) | 1993-12-01 | 1996-11-26 | Mcgill University | DNA methyltransferase antisense oligonucleotides |
| US5641754A (en) | 1994-01-10 | 1997-06-24 | The Board Of Regents Of The University Of Nebraska | Antisense oligonucleotide compositions for selectively killing cancer cells |
| EP0775204A1 (en) | 1994-08-09 | 1997-05-28 | Novartis AG | Antitumor antisense oligonucleotides |
| US5856103A (en) | 1994-10-07 | 1999-01-05 | Board Of Regents The University Of Texas | Method for selectively ranking sequences for antisense targeting |
| US5994320A (en) | 1995-02-06 | 1999-11-30 | Regents Of The University Of Minnesota | Antisense oligonucleotides and methods for treating central nervous system tumors |
| IT1275862B1 (it) | 1995-03-03 | 1997-10-24 | Consiglio Nazionale Ricerche | Trascritto antisenso associato ad alcuni tipi di cellule tumorali ed oligodeossinucleotidi sintetici utili nella diagnosi e nel trattamento |
| US6040296A (en) | 1995-06-07 | 2000-03-21 | East Carolina University | Specific antisense oligonucleotide composition & method for treatment of disorders associated with bronchoconstriction and lung inflammation |
| WO1997014709A1 (en) | 1995-10-13 | 1997-04-24 | F. Hoffmann-La Roche Ag | Antisense oligomers |
| JPH11507245A (ja) | 1995-11-21 | 1999-06-29 | アイシーエヌ・ファーマシューティカルズ・インコーポレイテッド | Ｉｌ―８およびｉｌ―８受容体に対するアンチセンスオリゴヌクレオチドによる睡瘍増殖の阻害 |
| AU708535B2 (en) | 1996-02-15 | 1999-08-05 | Cleveland Clinic Foundation, The | RNase L activators and antisense oligonucleotides effective to treat RSV infections |
| US5955590A (en) | 1996-07-15 | 1999-09-21 | Worcester Foundation For Biomedical Research | Conjugates of minor groove DNA binders with antisense oligonucleotides |
| US6046004A (en) | 1997-02-27 | 2000-04-04 | Lorne Park Research, Inc. | Solution hybridization of nucleic acids with antisense probes having modified backbones |
| JPH1142091A (ja) | 1997-07-25 | 1999-02-16 | Toagosei Co Ltd | アンチセンス核酸化合物 |
| US6046319A (en) | 1997-10-22 | 2000-04-04 | University Technologies International, Inc. | Antisense oligodeoxynucleotides regulating expression of TNF-α |
| IL136696A0 (en) * | 1997-12-23 | 2001-06-14 | Immunex Corp | Sigirr dna and polypeptides |
| US6007995A (en) | 1998-06-26 | 1999-12-28 | Isis Pharmaceuticals Inc. | Antisense inhibition of TNFR1 expression |
| US6013522A (en) | 1999-02-23 | 2000-01-11 | Isis Pharmaceuticals Inc. | Antisense inhibition of human Smad1 expression |
| US6025198A (en) | 1999-06-25 | 2000-02-15 | Isis Pharmaceuticals Inc. | Antisense modulation of Ship-2 expression |
| US6033910A (en) | 1999-07-19 | 2000-03-07 | Isis Pharmaceuticals Inc. | Antisense inhibition of MAP kinase kinase 6 expression |
| WO2013176772A1 (en) | 2012-05-25 | 2013-11-28 | The Regents Of The University Of California | Methods and compositions for rna-directed target dna modification and for rna-directed modulation of transcription |
| LT3138910T (lt) | 2012-12-06 | 2017-11-10 | Sigma-Aldrich Co. Llc | Crispr pagrįstas genomo modifikavimas ir reguliavimas |
| EP4230648A3 (en) | 2016-07-28 | 2023-10-18 | Regeneron Pharmaceuticals, Inc. | Gpr156 variants and uses thereof |
-
2018
- 2018-09-05 DK DK18779488.8T patent/DK3679158T3/da active
- 2018-09-05 WO PCT/US2018/049478 patent/WO2019050899A1/en not_active Ceased
- 2018-09-05 CN CN201880071851.1A patent/CN111373053B/zh active Active
- 2018-09-05 MX MX2020002643A patent/MX2020002643A/es unknown
- 2018-09-05 ES ES18779488T patent/ES3034207T3/es active Active
- 2018-09-05 FI FIEP18779488.8T patent/FI3679158T3/fi active
- 2018-09-05 US US16/644,650 patent/US20210071251A1/en active Pending
- 2018-09-05 JP JP2020513609A patent/JP7237064B2/ja active Active
- 2018-09-05 EP EP18779488.8A patent/EP3679158B1/en active Active
- 2018-09-05 NZ NZ762152A patent/NZ762152A/en unknown
- 2018-09-05 IL IL272940A patent/IL272940B2/en unknown
- 2018-09-05 KR KR1020207009809A patent/KR102752108B1/ko active Active
- 2018-09-05 AU AU2018328120A patent/AU2018328120B2/en active Active
- 2018-09-05 SG SG11202001754RA patent/SG11202001754RA/en unknown
- 2018-09-05 CA CA3074652A patent/CA3074652A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| IL272940B1 (en) | 2024-02-01 |
| SG11202001754RA (en) | 2020-03-30 |
| DK3679158T3 (da) | 2025-06-23 |
| CN111373053B (zh) | 2024-07-30 |
| JP2020537495A (ja) | 2020-12-24 |
| EP3679158B1 (en) | 2025-04-30 |
| FI3679158T3 (fi) | 2025-06-18 |
| RU2020112474A (ru) | 2021-10-06 |
| JP7237064B2 (ja) | 2023-03-10 |
| CN111373053A (zh) | 2020-07-03 |
| AU2018328120B2 (en) | 2024-11-14 |
| KR20200058435A (ko) | 2020-05-27 |
| NZ762152A (en) | 2025-11-28 |
| ES3034207T3 (en) | 2025-08-13 |
| CA3074652A1 (en) | 2019-03-14 |
| AU2018328120A1 (en) | 2020-03-19 |
| US20210071251A1 (en) | 2021-03-11 |
| KR102752108B1 (ko) | 2025-01-10 |
| WO2019050899A1 (en) | 2019-03-14 |
| EP3679158A1 (en) | 2020-07-15 |
| RU2020112474A3 (cg-RX-API-DMAC7.html) | 2021-12-29 |
| IL272940B2 (en) | 2024-06-01 |
| IL272940A (en) | 2020-04-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Shamriz et al. | Microbiota at the crossroads of autoimmunity | |
| MA40882B1 (fr) | Molécules de liaison d'antigène comprenant un trimère de ligand de la famille tnf | |
| CL2017002237A1 (es) | Proteína de unión de il-18 (il-18bp) y anticuerpos en enfermedades inflamatorias. | |
| MX385868B (es) | Proteina de union a interleucina 18 (il-18bp) en enfermedades inflamatorias. | |
| PH12019500596B1 (en) | Recombinant binding proteins and their use | |
| CY1119976T1 (el) | Μιμητικα καλσιτονινης για την αντιμετωπιση ασθενειων και διαταραχων | |
| BR112016016411A2 (pt) | VARIANTES DE REGIÕES-"Fc" COM PROPRIEDADES DE LIGAÇÃO DE "FcRn" MODIFICADAS | |
| WO2015175874A3 (en) | Molecules with altered neonate fc receptor binding having enhanced therapeutic and diagnostic properties | |
| NZ760289A (en) | Interleukin-2 fusion proteins and uses thereof | |
| MA32982B1 (fr) | Proteines de liaison au recepteur cgrp humain | |
| WO2015117088A3 (en) | Antibody based reagents that specifically recognize neurodegenerative disease related forms of the protein tdp-43 | |
| WO2020014097A8 (en) | Reagents and methods for treating cancer and autoimmune disease | |
| MX2024013403A (es) | Variantes de gpr156 y usos de estas | |
| WO2015198243A3 (en) | Compositions and methods for long acting proteins | |
| CO2020014681A2 (es) | Proteínas de unión al receptor de cannabinoides tipo 1 (cb1) y usos de las mismas | |
| CL2018001343A1 (es) | Lactoferrina para uso en el diagnóstico o el pronóstico de la enfermedad de alzheimer o en el diagnóstico de la enfermedad de parkinson | |
| NZ762152A (en) | Single immunoglobulin interleukin-1 receptor related (sigirr) variants and uses thereof | |
| EP4249503A3 (en) | Vsig8-based chimeric proteins | |
| Quan et al. | Kinetics of IL-23 and IL-12 secretion in response to Toxoplasma gondii antigens from THP-1 monocytic cells | |
| Almaguer-Mederos et al. | Normal ATXN2 alleles influences on the age at onset in spinocerebellar ataxia type 2 | |
| Nahm et al. | Proteomic identification of altered cerebral proteins in the complex regional pain syndrome animal model | |
| WO2015132397A3 (en) | Mitochondrial preproteins as markers for alzheimer's disease | |
| ZA202101755B (en) | Medicinal composition containing monoclonal antibody or antibody fab fragment thereof, and use thereof | |
| Onishi et al. | New Autoantigens Associated with Lupus Nephritis.: 1610 | |
| Bogdan et al. | The expression of the PIBF protein in mice during pregnancy: P-83 |